Cisplatin-Chelated Iminodiacetic Acid-Conjugated Hyaluronic Acid Nanogels for the Treatment of Malignant Pleural Mesothelioma in Mice

被引:10
作者
Amano, Yuki [1 ]
Sakura, Kazuma L. [2 ,3 ]
Ohta, Seiichi [1 ,4 ,5 ]
Ito, Taichi [1 ,4 ]
机构
[1] Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138656, Japan
[2] Osaka Univ Hosp, Resp Ctr, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Dept Surg, Suita, Osaka 5650871, Japan
[4] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan
[5] Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan
关键词
hyaluronic acid; cisplatin; nanogel; injectable hydrogel; malignant pleural mesothelioma; EXPRESSION; NANOPARTICLES; INCREASES; SYNTHASES; SIZE;
D O I
10.1021/acs.molpharmaceut.1c00797
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Malignant pleural mesothelioma (MPM) is one of the intractable cancers that require a more effective therapeutic strategy for clinical practice. Hyaluronic acid (HA) nanogels were prepared by the chelation of cisplatin (CDDP) with different molecular weights of iminodiacetic acid-conjugated hyaluronic acid (HA-IDA). The sizes of the 100, 850, and 2000 kDa HA nanogels were 33, 43, and 44 nm, respectively. MSTO-211H, a human MPM cell line, was more effective in taking up all three HA nanogels compared to AB22, a mouse MPM cell line. In addition, the 850 kDa HA nanogel showed higher anticancer activity against AB22 and MSTO-211H than 100 and 2000 kDa HA nanogels. Furthermore, all the HA nanogels showed a milder cytotoxic effect on normal Met-5A mesothelial cells compared to that exhibited by free CDDP. Finally, the 850 kDa HA nanogel was administrated intrapleurally into both the MSTO-211H xenograft and AB22 allograft mouse models of MPM using an injectable HA-based hydrogel. HA nanogels showed a significant therapeutic effect in both the xenograft and allograft models.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 32 条
[1]   Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells [J].
Albano, Giusy Daniela ;
Bonanno, Anna ;
Cavalieri, Luca ;
Ingrassia, Eleonora ;
Di Sano, Caterina ;
Siena, Liboria ;
Riccobono, Loredana ;
Gagliardo, Rosalia ;
Profita, Mirella .
MEDIATORS OF INFLAMMATION, 2016, 2016
[2]   Intrapleural polymeric films containing cisplatin for malignant pleural mesothelioma in a rat tumour model: a preliminary study [J].
Ampollini, Luca ;
Sonvico, Fabio ;
Barocelli, Elisabetta ;
Cavazzoni, Andrea ;
Bilancia, Rocco ;
Mucchino, Claudio ;
Cantoni, Anna Maria ;
Carbognani, Paolo .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (03) :557-565
[3]  
Baas Paul, 2007, Lung Cancer, V57 Suppl 2, pS24, DOI 10.1016/S0169-5002(07)70424-5
[4]   First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial [J].
Baas, Paul ;
Scherpereel, Arnaud ;
Nowak, Anna K. ;
Fujimoto, Nobukazu ;
Peters, Solange ;
Tsao, Anne S. ;
Mansfield, Aaron S. ;
Popat, Sanjay ;
Jahan, Thierry ;
Antonia, Scott ;
Oulkhouir, Youssef ;
Bautista, Yolanda ;
Cornelissen, Robin ;
Greillier, Laurent ;
Grossi, Francesco ;
Kowalski, Dariusz ;
Rodriguez-Cid, Jeronimo ;
Aanur, Praveen ;
Oukessou, Abderrahim ;
Baudelet, Christine ;
Zalcman, Gerard .
LANCET, 2021, 397 (10272) :375-386
[5]   Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma [J].
Chew, Shan Hwu ;
Okazaki, Yasumasa ;
Akatsuka, Shinya ;
Wang, Shenqi ;
Jiang, Li ;
Ohara, Yuuki ;
Ito, Fumiya ;
Saya, Hideyuki ;
Sekido, Yoshitaka ;
Toyokuni, Shinya .
FREE RADICAL BIOLOGY AND MEDICINE, 2017, 106 :91-99
[6]   Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells [J].
Chithrani, BD ;
Ghazani, AA ;
Chan, WCW .
NANO LETTERS, 2006, 6 (04) :662-668
[7]   The liberation of CD44 [J].
Cichy, J ;
Puré, E .
JOURNAL OF CELL BIOLOGY, 2003, 161 (05) :839-843
[8]   Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma [J].
Creaney, Jenette ;
Dick, Ian M. ;
Segal, Amanda ;
Musk, Arthur W. ;
Robinson, Bruce W. S. .
LUNG CANCER, 2013, 82 (03) :491-498
[9]   Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors [J].
Das, Satya ;
Johnson, Douglas B. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[10]   Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma [J].
Endo, Kazuhira ;
Ueno, Takayoshi ;
Kondo, Satoru ;
Wakisaka, Naohiro ;
Murono, Shigeyuki ;
Ito, Makoto ;
Kataoka, Kazunori ;
Kato, Yasuki ;
Yoshizaki, Tomokazu .
CANCER SCIENCE, 2013, 104 (03) :369-374